BIORA THERAPEUTICS, INC. 3/A SEC Filings

Filed On	Filing
24 Aug 2020	Form 3/A: Cooper Matthew T, Chief Scientific Officer Holds 44,178 shares of Common Stock
24 Aug 2020	Form 3/A: Shihabi Sami, Chief Commercial Officer Holds 40,374 shares of Common Stock
24 Aug 2020	Form 3/A: Silvestry Damon, Chief Operating Officer Holds 24,279 shares of Common Stock
24 Aug 2020	Form 3/A: Gianakopoulos George, Senior Vice President of Sales Holds 23,499 shares of Common Stock

Comments